Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Revenue of Establishment Labs Holdings Inc. (ESTA)
Revenue in 2023 (TTM): $165.15 M
According to Establishment Labs Holdings Inc.'s latest financial reports the company's current revenue (TTM) is $165.15 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Establishment Labs Holdings Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $165.15 M | $106.98 M | $-58,307,000 | $-78,583,000 | $-78,502,000 |
| 2022 | $161.7 M | $106.6 M | $-56,895,000 | $-72,824,000 | $-75,209,000 |
| 2021 | $126.68 M | $85.4 M | $-26,544,000 | $-39,712,000 | $-41,139,000 |
| 2020 | $84.68 M | $52.5 M | $-24,933,000 | $-38,017,000 | $-38,121,000 |
| 2019 | $89.57 M | $54.86 M | $-25,514,000 | $-37,510,000 | $-38,150,000 |
| 2018 | $61.21 M | $36.12 M | $-9,269,000 | $-20,883,000 | $-21,098,000 |
| 2017 | $34.68 M | $17.7 M | $-22,433,000 | $-34,792,000 | $-34,897,000 |
| 2016 | $19.8 M | $10.1 M | $-18,020,000 | $-22,025,000 | $-22,159,000 |